NCT01510067 Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus
| NCT ID | NCT01510067 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pennsylvania |
| Condition | Cutaneous Lupus Erythematosus (CLE) |
| Study Type | OBSERVATIONAL |
| Enrollment | 700 participants |
| Start Date | 2006-12 |
| Primary Completion | 2030-01-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 700 participants in total. It began in 2006-12 with a primary completion date of 2030-01-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Cutaneous Lupus Erythematosus (CLE) database, established in 2006, is a multi-site database between the University of Pennsylvania and the University of Texas Southwestern (UTSW).
Eligibility Criteria
Inclusion Criteria: * Subjects who meet the criteria for having CLE, using the Gilliam classifications, and/or a diagnosis of systemic lupus erythematosus (SLE), using the American Rheumatism Association/American College of Rheumatology criteria. Subjects must be 18 years or older. Exclusion Criteria: * All subjects who do not meet the criteria for having CLE. Subjects who meet the criteria for CLE but who are not yet 18 years old
Contact & Investigator
Victoria Werth, M.D.
PRINCIPAL INVESTIGATOR
University of Pennsylvania
Frequently Asked Questions
Who can join the NCT01510067 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cutaneous Lupus Erythematosus (CLE). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01510067 currently recruiting?
Yes, NCT01510067 is actively recruiting participants. Contact the research team at werth@pennmedicine.upenn.edu for enrollment information.
Where is the NCT01510067 trial being conducted?
This trial is being conducted at Philadelphia, United States, Dallas, United States.
Who is sponsoring the NCT01510067 clinical trial?
NCT01510067 is sponsored by University of Pennsylvania. The principal investigator is Victoria Werth, M.D. at University of Pennsylvania. The trial plans to enroll 700 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.